Dr Geoff Chong
Honorary (Principal Fellow)
Department of Medicine
44 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial
DOI: 10.1182/bloodadvances.20250165052025
Journal article
Prognostic Utility of Quantitative PET Parameters on Baseline and Interim FDG-PET Scans in Hodgkin Lymphoma
DOI: 10.1016/j.clml.2025.07.0052025
Journal article
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review
DOI: 10.1182/bloodadvances.20240150722025
Journal article
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 21st FLOR study
DOI: 10.1182/bloodadvances.20240154872025
Journal article
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
DOI: 10.1186/s12889-025-23925-42025
Journal article
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI
DOI: 10.1093/noajnl/vdaf0902024
Journal article
Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency
DOI: 10.1111/ajco.14076
RECENT SCHOLARLY WORKS
2024
Journal article
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
DOI: 10.1002/jha2.8702024
Conference Proceedings
Follicular Lymphoma Displays Distinct Gene Expression Profiles According to Histological Grade
DOI: 10.1182/blood-2024-2065712023
Journal article
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
DOI: 10.3324/haematol.2022.281375